Bladder cancer (BCa) is one of the 10 most common cancers with high morbidity and
mortality worldwide. Long noncoding RNAs (lncRNAs), a large class of noncoding RNA …

Bladder cancer (BC) is the most common malignant tumor in the urinary system, and its early
diagnosis is conducive to improving clinical prognosis and prolonging overall survival time …

The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …

Several reports over the last 10 years provided evidence that long noncoding RNAs
(lncRNAs) are often altered in bladder cancers. lncRNAs are longer than 200 nucleotides …

Bladder cancer (BC) is a common and serious type of cancer that ranks among the top ten
most prevalent malignancies worldwide. Due to the high occurrence rate of BC, the …

The advent of novel high-throughput sequencing methods has facilitated identification of
non-coding RNAs with fundamental roles in cellular biological and pathological conditions …

Abstract Background/Aims: Bladder cancer (BC) is one of the most frequent urologic tumors
worldwide. However, long non-coding RNA (lncRNA) expression profiles in BC progression …

Dysregulation of long noncoding RNAs (lncRNAs) has been regarded as a primary feature
of several human cancers. However, the genome‑wide expression and functional …

Long noncoding RNAs (lncRNAs) have been implicated playing important roles in human
urologic cancers. In the present study, microarray analysis was initially performed to screen …

Background Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …